Global Nausea And Vomiting Treatment Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Nausea And Vomiting Treatment market size is predicted to grow from US$ 5759 million in 2025 to US$ 8519 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.
Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
LPI (LP Information)' newest research report, the “Nausea And Vomiting Treatment Industry Forecast” looks at past sales and reviews total world Nausea And Vomiting Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Nausea And Vomiting Treatment sales for 2025 through 2031. With Nausea And Vomiting Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nausea And Vomiting Treatment industry.
This Insight Report provides a comprehensive analysis of the global Nausea And Vomiting Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nausea And Vomiting Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nausea And Vomiting Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nausea And Vomiting Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nausea And Vomiting Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Nausea And Vomiting Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Nausea And Vomiting Treatment market size is predicted to grow from US$ 5759 million in 2025 to US$ 8519 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.
Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
LPI (LP Information)' newest research report, the “Nausea And Vomiting Treatment Industry Forecast” looks at past sales and reviews total world Nausea And Vomiting Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Nausea And Vomiting Treatment sales for 2025 through 2031. With Nausea And Vomiting Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nausea And Vomiting Treatment industry.
This Insight Report provides a comprehensive analysis of the global Nausea And Vomiting Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nausea And Vomiting Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nausea And Vomiting Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nausea And Vomiting Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nausea And Vomiting Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Nausea And Vomiting Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Serotonin Receptor Antagonist
- Neurokinin NK1 Receptor Antagonist
- Others
- CINV
- PONV
- Motion Sickness
- Pregnancy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co. Inc.
- Helsinn Group
- Unimed Pharmaceuticals (AbbVie Inc.)
- Kyowa Kirin
- Sanofi
- Qilu Pharma
- Teva Pharmaceutical Industries Ltd.
- Taiji group
- Novartis
- Heron Therapeutics
- Pharmanovia
- Mylan
- Duchesnay
- GSK
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nausea And Vomiting Treatment Market Size (2020-2031)
2.1.2 Nausea And Vomiting Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nausea And Vomiting Treatment by Country/Region (2020, 2024 & 2031)
2.2 Nausea And Vomiting Treatment Segment by Type
2.2.1 Serotonin Receptor Antagonist
2.2.2 Neurokinin NK1 Receptor Antagonist
2.2.3 Others
2.3 Nausea And Vomiting Treatment Market Size by Type
2.3.1 Nausea And Vomiting Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nausea And Vomiting Treatment Market Size Market Share by Type (2020-2025)
2.4 Nausea And Vomiting Treatment Segment by Application
2.4.1 CINV
2.4.2 PONV
2.4.3 Motion Sickness
2.4.4 Pregnancy
2.4.5 Others
2.5 Nausea And Vomiting Treatment Market Size by Application
2.5.1 Nausea And Vomiting Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nausea And Vomiting Treatment Market Size Market Share by Application (2020-2025)
3 NAUSEA AND VOMITING TREATMENT MARKET SIZE BY PLAYER
3.1 Nausea And Vomiting Treatment Market Size Market Share by Player
3.1.1 Global Nausea And Vomiting Treatment Revenue by Player (2020-2025)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Nausea And Vomiting Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NAUSEA AND VOMITING TREATMENT BY REGION
4.1 Nausea And Vomiting Treatment Market Size by Region (2020-2025)
4.2 Global Nausea And Vomiting Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nausea And Vomiting Treatment Market Size Growth (2020-2025)
4.4 APAC Nausea And Vomiting Treatment Market Size Growth (2020-2025)
4.5 Europe Nausea And Vomiting Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nausea And Vomiting Treatment Market Size by Country (2020-2025)
5.2 Americas Nausea And Vomiting Treatment Market Size by Type (2020-2025)
5.3 Americas Nausea And Vomiting Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nausea And Vomiting Treatment Market Size by Region (2020-2025)
6.2 APAC Nausea And Vomiting Treatment Market Size by Type (2020-2025)
6.3 APAC Nausea And Vomiting Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nausea And Vomiting Treatment Market Size by Country (2020-2025)
7.2 Europe Nausea And Vomiting Treatment Market Size by Type (2020-2025)
7.3 Europe Nausea And Vomiting Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nausea And Vomiting Treatment by Region (2020-2025)
8.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NAUSEA AND VOMITING TREATMENT MARKET FORECAST
10.1 Global Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.1.1 Global Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.1.2 Americas Nausea And Vomiting Treatment Forecast
10.1.3 APAC Nausea And Vomiting Treatment Forecast
10.1.4 Europe Nausea And Vomiting Treatment Forecast
10.1.5 Middle East & Africa Nausea And Vomiting Treatment Forecast
10.2 Americas Nausea And Vomiting Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Nausea And Vomiting Treatment Forecast
10.2.2 Canada Market Nausea And Vomiting Treatment Forecast
10.2.3 Mexico Market Nausea And Vomiting Treatment Forecast
10.2.4 Brazil Market Nausea And Vomiting Treatment Forecast
10.3 APAC Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.3.1 China Nausea And Vomiting Treatment Market Forecast
10.3.2 Japan Market Nausea And Vomiting Treatment Forecast
10.3.3 Korea Market Nausea And Vomiting Treatment Forecast
10.3.4 Southeast Asia Market Nausea And Vomiting Treatment Forecast
10.3.5 India Market Nausea And Vomiting Treatment Forecast
10.3.6 Australia Market Nausea And Vomiting Treatment Forecast
10.4 Europe Nausea And Vomiting Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Nausea And Vomiting Treatment Forecast
10.4.2 France Market Nausea And Vomiting Treatment Forecast
10.4.3 UK Market Nausea And Vomiting Treatment Forecast
10.4.4 Italy Market Nausea And Vomiting Treatment Forecast
10.4.5 Russia Market Nausea And Vomiting Treatment Forecast
10.5 Middle East & Africa Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Nausea And Vomiting Treatment Forecast
10.5.2 South Africa Market Nausea And Vomiting Treatment Forecast
10.5.3 Israel Market Nausea And Vomiting Treatment Forecast
10.5.4 Turkey Market Nausea And Vomiting Treatment Forecast
10.6 Global Nausea And Vomiting Treatment Forecast by Type (2026-2031)
10.7 Global Nausea And Vomiting Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nausea And Vomiting Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Information
11.1.2 Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Merck & Co. Inc. Main Business Overview
11.1.5 Merck & Co. Inc. Latest Developments
11.2 Helsinn Group
11.2.1 Helsinn Group Company Information
11.2.2 Helsinn Group Nausea And Vomiting Treatment Product Offered
11.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Helsinn Group Main Business Overview
11.2.5 Helsinn Group Latest Developments
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Main Business Overview
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Information
11.4.2 Kyowa Kirin Nausea And Vomiting Treatment Product Offered
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Kyowa Kirin Main Business Overview
11.4.5 Kyowa Kirin Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Nausea And Vomiting Treatment Product Offered
11.5.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Information
11.6.2 Qilu Pharma Nausea And Vomiting Treatment Product Offered
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Qilu Pharma Main Business Overview
11.6.5 Qilu Pharma Latest Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Information
11.7.2 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.8 Taiji group
11.8.1 Taiji group Company Information
11.8.2 Taiji group Nausea And Vomiting Treatment Product Offered
11.8.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Taiji group Main Business Overview
11.8.5 Taiji group Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Nausea And Vomiting Treatment Product Offered
11.9.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Information
11.10.2 Heron Therapeutics Nausea And Vomiting Treatment Product Offered
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Heron Therapeutics Main Business Overview
11.10.5 Heron Therapeutics Latest Developments
11.11 Pharmanovia
11.11.1 Pharmanovia Company Information
11.11.2 Pharmanovia Nausea And Vomiting Treatment Product Offered
11.11.3 Pharmanovia Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Pharmanovia Main Business Overview
11.11.5 Pharmanovia Latest Developments
11.12 Mylan
11.12.1 Mylan Company Information
11.12.2 Mylan Nausea And Vomiting Treatment Product Offered
11.12.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Mylan Main Business Overview
11.12.5 Mylan Latest Developments
11.13 Duchesnay
11.13.1 Duchesnay Company Information
11.13.2 Duchesnay Nausea And Vomiting Treatment Product Offered
11.13.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Duchesnay Main Business Overview
11.13.5 Duchesnay Latest Developments
11.14 GSK
11.14.1 GSK Company Information
11.14.2 GSK Nausea And Vomiting Treatment Product Offered
11.14.3 GSK Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 GSK Main Business Overview
11.14.5 GSK Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Nausea And VomitingTreatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nausea And VomitingTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Serotonin Receptor Antagonist
Table 4. Major Players of Neurokinin NK1 Receptor Antagonist
Table 5. Major Players of Others
Table 6. Nausea And VomitingTreatment Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 8. Global Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Table 9. Nausea And VomitingTreatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Table 12. Global Nausea And VomitingTreatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Nausea And VomitingTreatment Revenue Market Share by Player (2020-2025)
Table 14. Nausea And VomitingTreatment Key Players Head office and Products Offered
Table 15. Nausea And VomitingTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nausea And VomitingTreatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Table 20. Global Nausea And VomitingTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Nausea And VomitingTreatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Nausea And VomitingTreatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Nausea And VomitingTreatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Table 26. Americas Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Nausea And VomitingTreatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Nausea And VomitingTreatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Nausea And VomitingTreatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nausea And VomitingTreatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Nausea And VomitingTreatment
Table 40. Key Market Challenges & Risks of Nausea And VomitingTreatment
Table 41. Key IndustryTrends of Nausea And VomitingTreatment
Table 42. Global Nausea And VomitingTreatment Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Nausea And VomitingTreatment Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Nausea And VomitingTreatment Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Nausea And VomitingTreatment Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Merck & Co. Inc. Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 47. Merck & Co. Inc. Nausea And VomitingTreatment Product Offered
Table 48. Merck & Co. Inc. Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Merck & Co. Inc. Main Business
Table 50. Merck & Co. Inc. Latest Developments
Table 51. Helsinn Group Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 52. Helsinn Group Nausea And VomitingTreatment Product Offered
Table 53. Helsinn Group Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Helsinn Group Main Business
Table 55. Helsinn Group Latest Developments
Table 56. Unimed Pharmaceuticals (AbbVie Inc.) Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 57. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And VomitingTreatment Product Offered
Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Unimed Pharmaceuticals (AbbVie Inc.) Main Business
Table 60. Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
Table 61. Kyowa Kirin Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 62. Kyowa Kirin Nausea And VomitingTreatment Product Offered
Table 63. Kyowa Kirin Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Kyowa Kirin Main Business
Table 65. Kyowa Kirin Latest Developments
Table 66. Sanofi Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 67. Sanofi Nausea And VomitingTreatment Product Offered
Table 68. Sanofi Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Sanofi Main Business
Table 70. Sanofi Latest Developments
Table 71. Qilu Pharma Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 72. Qilu Pharma Nausea And VomitingTreatment Product Offered
Table 73. Qilu Pharma Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Qilu Pharma Main Business
Table 75. Qilu Pharma Latest Developments
Table 76.Teva Pharmaceutical Industries Ltd. Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 77.Teva Pharmaceutical Industries Ltd. Nausea And VomitingTreatment Product Offered
Table 78.Teva Pharmaceutical Industries Ltd. Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79.Teva Pharmaceutical Industries Ltd. Main Business
Table 80.Teva Pharmaceutical Industries Ltd. Latest Developments
Table 81.Taiji group Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 82.Taiji group Nausea And VomitingTreatment Product Offered
Table 83.Taiji group Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84.Taiji group Main Business
Table 85.Taiji group Latest Developments
Table 86. Novartis Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 87. Novartis Nausea And VomitingTreatment Product Offered
Table 88. Novartis Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. HeronTherapeutics Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 92. HeronTherapeutics Nausea And VomitingTreatment Product Offered
Table 93. HeronTherapeutics Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. HeronTherapeutics Main Business
Table 95. HeronTherapeutics Latest Developments
Table 96. Pharmanovia Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 97. Pharmanovia Nausea And VomitingTreatment Product Offered
Table 98. Pharmanovia Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Pharmanovia Main Business
Table 100. Pharmanovia Latest Developments
Table 101. Mylan Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 102. Mylan Nausea And VomitingTreatment Product Offered
Table 103. Mylan Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Mylan Main Business
Table 105. Mylan Latest Developments
Table 106. Duchesnay Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 107. Duchesnay Nausea And VomitingTreatment Product Offered
Table 108. Duchesnay Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Duchesnay Main Business
Table 110. Duchesnay Latest Developments
Table 111. GSK Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 112. GSK Nausea And VomitingTreatment Product Offered
Table 113. GSK Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. GSK Main Business
Table 115. GSK Latest Developments
LIST OFFIGURES
Figure 1. Nausea And VomitingTreatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nausea And VomitingTreatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nausea And VomitingTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nausea And VomitingTreatment Sales Market Share by Country/Region (2024)
Figure 8. Nausea And VomitingTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nausea And VomitingTreatment Market Size Market Share byType in 2024
Figure 10. Nausea And VomitingTreatment in CINV
Figure 11. Global Nausea And VomitingTreatment Market: CINV (2020-2025) & ($ millions)
Figure 12. Nausea And VomitingTreatment in PONV
Figure 13. Global Nausea And VomitingTreatment Market: PONV (2020-2025) & ($ millions)
Figure 14. Nausea And VomitingTreatment in Motion Sickness
Figure 15. Global Nausea And VomitingTreatment Market: Motion Sickness (2020-2025) & ($ millions)
Figure 16. Nausea And VomitingTreatment in Pregnancy
Figure 17. Global Nausea And VomitingTreatment Market: Pregnancy (2020-2025) & ($ millions)
Figure 18. Nausea And VomitingTreatment in Others
Figure 19. Global Nausea And VomitingTreatment Market: Others (2020-2025) & ($ millions)
Figure 20. Global Nausea And VomitingTreatment Market Size Market Share by Application in 2024
Figure 21. Global Nausea And VomitingTreatment Revenue Market Share by Player in 2024
Figure 22. Global Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Figure 23. Americas Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 24. APAC Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 25. Europe Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 27. Americas Nausea And VomitingTreatment Value Market Share by Country in 2024
Figure 28. United States Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Nausea And VomitingTreatment Market Size Market Share by Region in 2024
Figure 33. APAC Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Figure 34. APAC Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Figure 35. China Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 39. India Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Nausea And VomitingTreatment Market Size Market Share by Country in 2024
Figure 42. Europe Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Figure 43. Europe Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Figure 44. Germany Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 45.France Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 58. APAC Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 59. Europe Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 61. United States Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 62. Canada Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 63. Mexico Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 64. Brazil Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 65. China Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 66. Japan Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 67. Korea Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 69. India Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 70. Australia Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 71. Germany Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 72.France Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 73. UK Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 74. Italy Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 75. Russia Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 76. Egypt Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 77. South Africa Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 78. Israel Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 79.Turkey Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 80. Global Nausea And VomitingTreatment Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Nausea And VomitingTreatment Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nausea And Vomiting Treatment Market Size (2020-2031)
2.1.2 Nausea And Vomiting Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nausea And Vomiting Treatment by Country/Region (2020, 2024 & 2031)
2.2 Nausea And Vomiting Treatment Segment by Type
2.2.1 Serotonin Receptor Antagonist
2.2.2 Neurokinin NK1 Receptor Antagonist
2.2.3 Others
2.3 Nausea And Vomiting Treatment Market Size by Type
2.3.1 Nausea And Vomiting Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nausea And Vomiting Treatment Market Size Market Share by Type (2020-2025)
2.4 Nausea And Vomiting Treatment Segment by Application
2.4.1 CINV
2.4.2 PONV
2.4.3 Motion Sickness
2.4.4 Pregnancy
2.4.5 Others
2.5 Nausea And Vomiting Treatment Market Size by Application
2.5.1 Nausea And Vomiting Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nausea And Vomiting Treatment Market Size Market Share by Application (2020-2025)
3 NAUSEA AND VOMITING TREATMENT MARKET SIZE BY PLAYER
3.1 Nausea And Vomiting Treatment Market Size Market Share by Player
3.1.1 Global Nausea And Vomiting Treatment Revenue by Player (2020-2025)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Nausea And Vomiting Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NAUSEA AND VOMITING TREATMENT BY REGION
4.1 Nausea And Vomiting Treatment Market Size by Region (2020-2025)
4.2 Global Nausea And Vomiting Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nausea And Vomiting Treatment Market Size Growth (2020-2025)
4.4 APAC Nausea And Vomiting Treatment Market Size Growth (2020-2025)
4.5 Europe Nausea And Vomiting Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Nausea And Vomiting Treatment Market Size by Country (2020-2025)
5.2 Americas Nausea And Vomiting Treatment Market Size by Type (2020-2025)
5.3 Americas Nausea And Vomiting Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nausea And Vomiting Treatment Market Size by Region (2020-2025)
6.2 APAC Nausea And Vomiting Treatment Market Size by Type (2020-2025)
6.3 APAC Nausea And Vomiting Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nausea And Vomiting Treatment Market Size by Country (2020-2025)
7.2 Europe Nausea And Vomiting Treatment Market Size by Type (2020-2025)
7.3 Europe Nausea And Vomiting Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nausea And Vomiting Treatment by Region (2020-2025)
8.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NAUSEA AND VOMITING TREATMENT MARKET FORECAST
10.1 Global Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.1.1 Global Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.1.2 Americas Nausea And Vomiting Treatment Forecast
10.1.3 APAC Nausea And Vomiting Treatment Forecast
10.1.4 Europe Nausea And Vomiting Treatment Forecast
10.1.5 Middle East & Africa Nausea And Vomiting Treatment Forecast
10.2 Americas Nausea And Vomiting Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Nausea And Vomiting Treatment Forecast
10.2.2 Canada Market Nausea And Vomiting Treatment Forecast
10.2.3 Mexico Market Nausea And Vomiting Treatment Forecast
10.2.4 Brazil Market Nausea And Vomiting Treatment Forecast
10.3 APAC Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.3.1 China Nausea And Vomiting Treatment Market Forecast
10.3.2 Japan Market Nausea And Vomiting Treatment Forecast
10.3.3 Korea Market Nausea And Vomiting Treatment Forecast
10.3.4 Southeast Asia Market Nausea And Vomiting Treatment Forecast
10.3.5 India Market Nausea And Vomiting Treatment Forecast
10.3.6 Australia Market Nausea And Vomiting Treatment Forecast
10.4 Europe Nausea And Vomiting Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Nausea And Vomiting Treatment Forecast
10.4.2 France Market Nausea And Vomiting Treatment Forecast
10.4.3 UK Market Nausea And Vomiting Treatment Forecast
10.4.4 Italy Market Nausea And Vomiting Treatment Forecast
10.4.5 Russia Market Nausea And Vomiting Treatment Forecast
10.5 Middle East & Africa Nausea And Vomiting Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Nausea And Vomiting Treatment Forecast
10.5.2 South Africa Market Nausea And Vomiting Treatment Forecast
10.5.3 Israel Market Nausea And Vomiting Treatment Forecast
10.5.4 Turkey Market Nausea And Vomiting Treatment Forecast
10.6 Global Nausea And Vomiting Treatment Forecast by Type (2026-2031)
10.7 Global Nausea And Vomiting Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nausea And Vomiting Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Information
11.1.2 Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Merck & Co. Inc. Main Business Overview
11.1.5 Merck & Co. Inc. Latest Developments
11.2 Helsinn Group
11.2.1 Helsinn Group Company Information
11.2.2 Helsinn Group Nausea And Vomiting Treatment Product Offered
11.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Helsinn Group Main Business Overview
11.2.5 Helsinn Group Latest Developments
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Main Business Overview
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Information
11.4.2 Kyowa Kirin Nausea And Vomiting Treatment Product Offered
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Kyowa Kirin Main Business Overview
11.4.5 Kyowa Kirin Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Nausea And Vomiting Treatment Product Offered
11.5.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Information
11.6.2 Qilu Pharma Nausea And Vomiting Treatment Product Offered
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Qilu Pharma Main Business Overview
11.6.5 Qilu Pharma Latest Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Information
11.7.2 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.8 Taiji group
11.8.1 Taiji group Company Information
11.8.2 Taiji group Nausea And Vomiting Treatment Product Offered
11.8.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Taiji group Main Business Overview
11.8.5 Taiji group Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Nausea And Vomiting Treatment Product Offered
11.9.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Information
11.10.2 Heron Therapeutics Nausea And Vomiting Treatment Product Offered
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Heron Therapeutics Main Business Overview
11.10.5 Heron Therapeutics Latest Developments
11.11 Pharmanovia
11.11.1 Pharmanovia Company Information
11.11.2 Pharmanovia Nausea And Vomiting Treatment Product Offered
11.11.3 Pharmanovia Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Pharmanovia Main Business Overview
11.11.5 Pharmanovia Latest Developments
11.12 Mylan
11.12.1 Mylan Company Information
11.12.2 Mylan Nausea And Vomiting Treatment Product Offered
11.12.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Mylan Main Business Overview
11.12.5 Mylan Latest Developments
11.13 Duchesnay
11.13.1 Duchesnay Company Information
11.13.2 Duchesnay Nausea And Vomiting Treatment Product Offered
11.13.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Duchesnay Main Business Overview
11.13.5 Duchesnay Latest Developments
11.14 GSK
11.14.1 GSK Company Information
11.14.2 GSK Nausea And Vomiting Treatment Product Offered
11.14.3 GSK Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 GSK Main Business Overview
11.14.5 GSK Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Nausea And VomitingTreatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Nausea And VomitingTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Serotonin Receptor Antagonist
Table 4. Major Players of Neurokinin NK1 Receptor Antagonist
Table 5. Major Players of Others
Table 6. Nausea And VomitingTreatment Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 8. Global Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Table 9. Nausea And VomitingTreatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Table 12. Global Nausea And VomitingTreatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Nausea And VomitingTreatment Revenue Market Share by Player (2020-2025)
Table 14. Nausea And VomitingTreatment Key Players Head office and Products Offered
Table 15. Nausea And VomitingTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nausea And VomitingTreatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Table 20. Global Nausea And VomitingTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Nausea And VomitingTreatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Nausea And VomitingTreatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Nausea And VomitingTreatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Table 26. Americas Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Nausea And VomitingTreatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Nausea And VomitingTreatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Nausea And VomitingTreatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Nausea And VomitingTreatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Nausea And VomitingTreatment Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Nausea And VomitingTreatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Nausea And VomitingTreatment
Table 40. Key Market Challenges & Risks of Nausea And VomitingTreatment
Table 41. Key IndustryTrends of Nausea And VomitingTreatment
Table 42. Global Nausea And VomitingTreatment Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Nausea And VomitingTreatment Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Nausea And VomitingTreatment Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Nausea And VomitingTreatment Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Merck & Co. Inc. Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 47. Merck & Co. Inc. Nausea And VomitingTreatment Product Offered
Table 48. Merck & Co. Inc. Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Merck & Co. Inc. Main Business
Table 50. Merck & Co. Inc. Latest Developments
Table 51. Helsinn Group Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 52. Helsinn Group Nausea And VomitingTreatment Product Offered
Table 53. Helsinn Group Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Helsinn Group Main Business
Table 55. Helsinn Group Latest Developments
Table 56. Unimed Pharmaceuticals (AbbVie Inc.) Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 57. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And VomitingTreatment Product Offered
Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Unimed Pharmaceuticals (AbbVie Inc.) Main Business
Table 60. Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
Table 61. Kyowa Kirin Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 62. Kyowa Kirin Nausea And VomitingTreatment Product Offered
Table 63. Kyowa Kirin Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Kyowa Kirin Main Business
Table 65. Kyowa Kirin Latest Developments
Table 66. Sanofi Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 67. Sanofi Nausea And VomitingTreatment Product Offered
Table 68. Sanofi Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Sanofi Main Business
Table 70. Sanofi Latest Developments
Table 71. Qilu Pharma Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 72. Qilu Pharma Nausea And VomitingTreatment Product Offered
Table 73. Qilu Pharma Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Qilu Pharma Main Business
Table 75. Qilu Pharma Latest Developments
Table 76.Teva Pharmaceutical Industries Ltd. Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 77.Teva Pharmaceutical Industries Ltd. Nausea And VomitingTreatment Product Offered
Table 78.Teva Pharmaceutical Industries Ltd. Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79.Teva Pharmaceutical Industries Ltd. Main Business
Table 80.Teva Pharmaceutical Industries Ltd. Latest Developments
Table 81.Taiji group Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 82.Taiji group Nausea And VomitingTreatment Product Offered
Table 83.Taiji group Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84.Taiji group Main Business
Table 85.Taiji group Latest Developments
Table 86. Novartis Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 87. Novartis Nausea And VomitingTreatment Product Offered
Table 88. Novartis Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. HeronTherapeutics Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 92. HeronTherapeutics Nausea And VomitingTreatment Product Offered
Table 93. HeronTherapeutics Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. HeronTherapeutics Main Business
Table 95. HeronTherapeutics Latest Developments
Table 96. Pharmanovia Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 97. Pharmanovia Nausea And VomitingTreatment Product Offered
Table 98. Pharmanovia Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Pharmanovia Main Business
Table 100. Pharmanovia Latest Developments
Table 101. Mylan Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 102. Mylan Nausea And VomitingTreatment Product Offered
Table 103. Mylan Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Mylan Main Business
Table 105. Mylan Latest Developments
Table 106. Duchesnay Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 107. Duchesnay Nausea And VomitingTreatment Product Offered
Table 108. Duchesnay Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Duchesnay Main Business
Table 110. Duchesnay Latest Developments
Table 111. GSK Details, CompanyType, Nausea And VomitingTreatment Area Served and Its Competitors
Table 112. GSK Nausea And VomitingTreatment Product Offered
Table 113. GSK Nausea And VomitingTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. GSK Main Business
Table 115. GSK Latest Developments
LIST OFFIGURES
Figure 1. Nausea And VomitingTreatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nausea And VomitingTreatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Nausea And VomitingTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Nausea And VomitingTreatment Sales Market Share by Country/Region (2024)
Figure 8. Nausea And VomitingTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Nausea And VomitingTreatment Market Size Market Share byType in 2024
Figure 10. Nausea And VomitingTreatment in CINV
Figure 11. Global Nausea And VomitingTreatment Market: CINV (2020-2025) & ($ millions)
Figure 12. Nausea And VomitingTreatment in PONV
Figure 13. Global Nausea And VomitingTreatment Market: PONV (2020-2025) & ($ millions)
Figure 14. Nausea And VomitingTreatment in Motion Sickness
Figure 15. Global Nausea And VomitingTreatment Market: Motion Sickness (2020-2025) & ($ millions)
Figure 16. Nausea And VomitingTreatment in Pregnancy
Figure 17. Global Nausea And VomitingTreatment Market: Pregnancy (2020-2025) & ($ millions)
Figure 18. Nausea And VomitingTreatment in Others
Figure 19. Global Nausea And VomitingTreatment Market: Others (2020-2025) & ($ millions)
Figure 20. Global Nausea And VomitingTreatment Market Size Market Share by Application in 2024
Figure 21. Global Nausea And VomitingTreatment Revenue Market Share by Player in 2024
Figure 22. Global Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Figure 23. Americas Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 24. APAC Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 25. Europe Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Nausea And VomitingTreatment Market Size 2020-2025 ($ millions)
Figure 27. Americas Nausea And VomitingTreatment Value Market Share by Country in 2024
Figure 28. United States Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Nausea And VomitingTreatment Market Size Market Share by Region in 2024
Figure 33. APAC Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Figure 34. APAC Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Figure 35. China Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 39. India Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Nausea And VomitingTreatment Market Size Market Share by Country in 2024
Figure 42. Europe Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Figure 43. Europe Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Figure 44. Germany Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 45.France Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Nausea And VomitingTreatment Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Nausea And VomitingTreatment Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Nausea And VomitingTreatment Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Nausea And VomitingTreatment Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 58. APAC Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 59. Europe Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 61. United States Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 62. Canada Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 63. Mexico Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 64. Brazil Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 65. China Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 66. Japan Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 67. Korea Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 69. India Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 70. Australia Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 71. Germany Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 72.France Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 73. UK Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 74. Italy Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 75. Russia Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 76. Egypt Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 77. South Africa Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 78. Israel Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 79.Turkey Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
Figure 80. Global Nausea And VomitingTreatment Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Nausea And VomitingTreatment Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Nausea And VomitingTreatment Market Size 2026-2031 ($ millions)
